Cerus (CERS) Cash & Current Investments (2010 - 2026)
Cerus (CERS) posted Cash & Current Investments of $56.3 million for Q2 2026, down 30.04% sequentially from $80.4 million in Q1 2026, and down 27.89% YoY from $78.0 million in Q2 2025.
Cerus (CERS) Cash & Current Investments (2010 - 2026) Analysis & Trends
Cerus has reported Cash & Current Investments for 17 years, with the latest figure at $56.3 million in Q2 2026.
- Quarterly Cash & Current Investments fell 27.89% year-over-year to $56.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $56.3 million (down 27.89% YoY) and the FY2025 annual result came in at $82.9 million, up 3.02% from the prior year.
- Cash & Current Investments retreated to $56.3 million in Q2 2026 per CERS's latest filing, from $80.4 million in the prior quarter.
- Over five years, Cash & Current Investments peaked at $108.6 million in Q1 2022 and troughed at $56.3 million in Q2 2026.
- A 5-year average of $83.4 million and a median of $80.4 million in 2024 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2023 and 2024: Cash & Current Investments sank 35.54% in 2023, then grew 22.17% in 2024.
- Over 5 years, Cash & Current Investments stood at $102.2 million in 2022, then tumbled by 35.54% to $65.9 million in 2023, then rose by 22.17% to $80.5 million in 2024, then increased by 3.02% to $82.9 million in 2025, then plunged by 32.11% to $56.3 million in 2026.
- According to Business Quant data, Cash & Current Investments over the past three periods registered $56.3 million, $80.4 million, and $82.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Cerus | 560.58 Mn | 504.32 Mn | 29.53 Mn | 56.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 56.26 Mn |
| Mar 31, 2026 | 80.43 Mn |
| Dec 31, 2025 | 82.88 Mn |
| Sep 30, 2025 | 78.51 Mn |
| Jun 30, 2025 | 78.03 Mn |
| Mar 31, 2025 | 80.92 Mn |
| Dec 31, 2024 | 80.45 Mn |
| Sep 30, 2024 | 75.57 Mn |
| Jun 30, 2024 | 71.19 Mn |
| Mar 31, 2024 | 72.18 Mn |
| Dec 31, 2023 | 65.85 Mn |
| Sep 30, 2023 | 79.01 Mn |
| Jun 30, 2023 | 84.50 Mn |
| Mar 31, 2023 | 94.68 Mn |
| Dec 31, 2022 | 102.15 Mn |
| Sep 30, 2022 | 103.83 Mn |
| Jun 30, 2022 | 107.05 Mn |
| Mar 31, 2022 | 108.56 Mn |
| Dec 31, 2021 | 129.36 Mn |
| Sep 30, 2021 | 119.96 Mn |